Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Looking for income without a second job? Check out these innovative ways to make money without adding more hours to your day.
23,599 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
As volatility in Bitcoin keeps traders on edge, JPMorgan analysts argue that cash may be the stabilizer behind a bitc...
A casual farm moment turns into a masterclass in budget-friendly self-care. Learn practical steps to embrace natural ...
Promotional sign up offers can turbocharge your rewards, but they’re easy to misread. This expert guide breaks down h...
A high-profile wedding followed by a Montana mini-moon illustrates the money choices, privacy concerns, and planning ...
When a celebrity moment goes beyond fashion, it becomes a teachable moment for money. This piece breaks down the fina...
Peek behind the curtain of a renowned star’s private life. This fictional profile of the Neill family reveals how mon...
Lawmakers warn that granting a national bank charter to a crypto-focused issuer could undermine financial integrity a...
As SpaceX eyes the public markets, investors buzz about a potential IPO rush and a comeback for stock-split enthusias...
Starting with $1,000 doesn’t have to be overwhelming. This guide breaks down the smartest Vanguard ETF options, a sim...
SUI has introduced gasless stablecoin transfers, eliminating on-chain fees for supported assets and expanding enterpr...
When disasters hit, celebrities can rally support in powerful ways. This guide shows you how to give wisely, budget f...